Avesthagen granted US patent

has been granted patent by the US for "breakthrough" and eco-friendly safe selection method that can replace the traditional antibiotic marker technology in GM crops.

In the past, antibiotic resistance marker gene(s) have been used for developing GM crops which has raised world-wide opposition to the GM technology in general, Avesthagen said in a statement.

"Avesthagen’s Xylose Isomerase [XI] technology does not use antibiotics in the selection process thus successfully addressing public concerns. This positive selection process is based on the function imparted by the patented technology to metabolise certain carbohydrate compounds during the selection process," it said.

The transformation efficiency of the patented method is approximately two to three times that of the antibiotic based methods thereby increasing the chances of success of identifying transformed cells.

The present patent has been granted towards improvement in the method of generating engineered plantlets with novel genes and can be extended to trait stacking with multiple genes which requires several markers in the selection process.

The patent was also granted for sunflower transformation. This is the first such patent granted for a recalcitrant species. This will unfold a new market outlook for sunflower seed and oil industry, it said.

Avesthagen said sunflower is an important oil-seed crop with high potential to increase the production of specific polyunsaturated fatty acids (PUFAs) essential for human health.

Certain polyunsaturated fatty acids should be part of human supplementary diet as the human body cannot synthesise them. Avesthagen’s patented technology has enhanced sunflower transformation process thus assisting in the process of producing PUFAs, it said.

"This patent gives Avesthagen significant freedom to operate in the global Agricultural Biotech Industry," the company said.

image
Business Standard
177 22
Business Standard

Avesthagen granted US patent

Press Trust of India  |  Bangalore 



has been granted patent by the US for "breakthrough" and eco-friendly safe selection method that can replace the traditional antibiotic marker technology in GM crops.

In the past, antibiotic resistance marker gene(s) have been used for developing GM crops which has raised world-wide opposition to the GM technology in general, Avesthagen said in a statement.

"Avesthagen’s Xylose Isomerase [XI] technology does not use antibiotics in the selection process thus successfully addressing public concerns. This positive selection process is based on the function imparted by the patented technology to metabolise certain carbohydrate compounds during the selection process," it said.

The transformation efficiency of the patented method is approximately two to three times that of the antibiotic based methods thereby increasing the chances of success of identifying transformed cells.

The present patent has been granted towards improvement in the method of generating engineered plantlets with novel genes and can be extended to trait stacking with multiple genes which requires several markers in the selection process.

The patent was also granted for sunflower transformation. This is the first such patent granted for a recalcitrant species. This will unfold a new market outlook for sunflower seed and oil industry, it said.

Avesthagen said sunflower is an important oil-seed crop with high potential to increase the production of specific polyunsaturated fatty acids (PUFAs) essential for human health.

Certain polyunsaturated fatty acids should be part of human supplementary diet as the human body cannot synthesise them. Avesthagen’s patented technology has enhanced sunflower transformation process thus assisting in the process of producing PUFAs, it said.

"This patent gives Avesthagen significant freedom to operate in the global Agricultural Biotech Industry," the company said.

RECOMMENDED FOR YOU

Avesthagen granted US patent

Avesthagen has been granted patent by the US for "breakthrough" sunflower transformation and eco-friendly safe selection method that can replace the traditional antibiotic marker technology in GM crops.

has been granted patent by the US for "breakthrough" and eco-friendly safe selection method that can replace the traditional antibiotic marker technology in GM crops.

In the past, antibiotic resistance marker gene(s) have been used for developing GM crops which has raised world-wide opposition to the GM technology in general, Avesthagen said in a statement.

"Avesthagen’s Xylose Isomerase [XI] technology does not use antibiotics in the selection process thus successfully addressing public concerns. This positive selection process is based on the function imparted by the patented technology to metabolise certain carbohydrate compounds during the selection process," it said.

The transformation efficiency of the patented method is approximately two to three times that of the antibiotic based methods thereby increasing the chances of success of identifying transformed cells.

The present patent has been granted towards improvement in the method of generating engineered plantlets with novel genes and can be extended to trait stacking with multiple genes which requires several markers in the selection process.

The patent was also granted for sunflower transformation. This is the first such patent granted for a recalcitrant species. This will unfold a new market outlook for sunflower seed and oil industry, it said.

Avesthagen said sunflower is an important oil-seed crop with high potential to increase the production of specific polyunsaturated fatty acids (PUFAs) essential for human health.

Certain polyunsaturated fatty acids should be part of human supplementary diet as the human body cannot synthesise them. Avesthagen’s patented technology has enhanced sunflower transformation process thus assisting in the process of producing PUFAs, it said.

"This patent gives Avesthagen significant freedom to operate in the global Agricultural Biotech Industry," the company said.

image
Business Standard
177 22
Widgets Magazine

More News

  • Bhavin Turakhia, founder and chief executive, Directi Group We focused on creating value, not valuation: Bhavin Turakhia
  • (From left to right)  Ralf Speth, Global CEO Jaguar Land Rover, Guenter Butschek, Tata Motors and Ravindra Pisharody, ED, Commercial Vehicles Business Unit, Tata Motors Ltd Ltd announcing company's Q1 results in Mumbai (Pic: Kamlesh Pednekar) Tata Motors net down 57% in June quarter
Widgets Magazine
Widgets Magazine

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard